VTRS Stock Overview
Operates as a healthcare company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.37 |
| 52 Week High | US$13.62 |
| 52 Week Low | US$9.08 |
| Beta | 0.93 |
| 11 Month Change | 15.76% |
| 3 Month Change | 13.69% |
| 1 Year Change | 41.78% |
| 33 Year Change | 4.86% |
| 5 Year Change | -28.81% |
| Change since IPO | 2,080.48% |
Recent News & Updates
Bargain Priced Viatris Reports Strong Q3 Earnings Results
Nov 08Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A Buy
Oct 22Recent updates
Bargain Priced Viatris Reports Strong Q3 Earnings Results
Nov 08Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A Buy
Oct 22Viatris: Revenues, Debt, Valuation And Strategy Under The Microscope
Jun 13Viatris: Skeptics Proven Right Once Again
May 30Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.
Apr 24Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential
Apr 08Viatris Stock Is Still Worth Buying
Mar 30Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued
Mar 02From Euphoria To Reality: Viatris' Tale Of Market Whirlwind
Jan 12Shareholder Returns
| VTRS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 4.2% | 1.6% | 2.2% |
| 1Y | 41.8% | 10.0% | 31.7% |
Return vs Industry: VTRS exceeded the US Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: VTRS exceeded the US Market which returned 31.7% over the past year.
Price Volatility
| VTRS volatility | |
|---|---|
| VTRS Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VTRS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: VTRS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 32,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VTRS fundamental statistics | |
|---|---|
| Market cap | US$15.82b |
| Earnings (TTM) | -US$883.30m |
| Revenue (TTM) | US$15.05b |
1.1x
P/S Ratio-18.1x
P/E RatioIs VTRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRS income statement (TTM) | |
|---|---|
| Revenue | US$15.05b |
| Cost of Revenue | US$8.72b |
| Gross Profit | US$6.32b |
| Other Expenses | US$7.21b |
| Earnings | -US$883.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 42.03% |
| Net Profit Margin | -5.87% |
| Debt/Equity Ratio | 79.5% |
How did VTRS perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield-65%
Payout RatioDoes VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks| Viatris dividend dates | |
|---|---|
| Ex Dividend Date | Nov 22 2024 |
| Dividend Pay Date | Dec 13 2024 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 20 days |
Does VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks